文献速递妇科产科

子宫内膜癌原发灶与转移灶间PD-L1和PD-1表达高度异质

High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2020-01-21

本研究基于700例子宫内膜癌前瞻性人群队列,采用新鲜组织基因表达分析检测PD-L1和PD-1,其中分别有68例和74例可获得对应转移灶。原发肿瘤中PD-L1和PD-1表达率分别为59%和63%,对生存无影响,MSS与MSI肿瘤表达模式相似;转移灶表达与原发灶不一致。

要点

  • 原发子宫内膜癌中PD-L1和PD-1表达率分别为59%和63%。
  • PD-L1/PD-1表达对生存无影响,MSS与MSI表达模式相似。
  • 转移灶PD-L1/PD-1表达与原发灶不一致,影响晚期治疗决策。

核心结论

  • PD-L1和PD-1在子宫内膜癌中频繁表达,MSS与MSI肿瘤表达模式相似。
  • 对应转移灶中PD-L1和PD-1表达与原发肿瘤不一致,对晚期和复发疾病治疗决策有特别意义。

研究设计与样本

  • 前瞻性人群基础子宫内膜癌队列,共700例患者。
  • 分别有68例和74例患者可获得对应转移灶用于PD-L1和PD-1检测。
  • 采用新鲜组织进行基因表达分析。

主要发现

  • 原发肿瘤中PD-L1表达率为59%,PD-1表达率为63%。
  • PD-L1和PD-1表达对生存无影响,按MSS和MSI分层后亦无影响。
  • MSI与MSS肿瘤中PD-L1和PD-1表达模式相似。
  • 可获得的转移灶显示PD-L1和PD-1表达异质。
  • 基因表达分析中,PD-1阳性肿瘤中多个免疫活性相关基因上调,包括CD274(编码PD-L1)。

临床怎么用

  • 晚期或复发子宫内膜癌的免疫治疗决策需考虑转移灶PD-L1/PD-1表达与原发灶的不一致。
  • 原发灶PD-L1/PD-1表达状态可能不能代表转移灶情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: PD-L1 and PD-1 are predictive markers for immunotherapy and increasingly relevant in endometrial cancer. The reported fraction of positive primary tumors has been inconsistent. We investigated the expression of PD-L1 and PD-1 in primary tumors, also stratified by MSI. As immunotherapy is foremost relevant for metastatic disease, PD-L1 and PD-1 expression was also assessed in corresponding metastatic lesions. METHODS: PD-L1 and PD-1 was investigated in a prospective, population based endometrial cancer cohort of 700 patients with corresponding metastatic lesions from 68 and 74 patients respectively. Fresh tissue was used for gene expression analysis. RESULTS: In primary tumors, PD-L1 and PD-1 are expressed in 59% and 63%, respectively, but with no impact on survival, nor when stratified for MSS and MSI. Expression patterns of PD-L1 and PD-1 are similar in MSI and MSS tumors. Available metastatic lesions show heterogeneous expression of PD-L1 and PD-1. In gene expression analysis several genes related to immunological activity, including CD274 (encoding for PD-L1), were upregulated in PD-1 positive tumors. CONCLUSION: PD-L1 and PD-1 are frequently expressed in endometrial cancer and expression patterns are similar across MSS and MSI tumors. Expression in corresponding metastatic lesions is discordant compared to primary tumors. These findings are in particular relevant for treatment decisions in advanced and recurrent disease.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Engerud H, Berg HF, Myrvold M, et al. High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. Gynecol Oncol. 2020. PMID: 31973911. doi:10.1016/j.ygyno.2020.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。